Clinical Trial Update: PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating PD-1 knockout anti-MUC1 CAR-T cells for advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PD-1 knockout anti-MUC1 CAR-T cells (PD-1 knockout anti-MUC1 CAR-T cells)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Advanced Breast Cancer, Breast Neoplasm Malignant Female | Phase 1, Phase 2 | Status: COMPLETED